Month: September 2024

TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (“ERES”) (TSX:ERE.UN) announced today it will issue its financial results for the three and nine months ended September 30, 2024 after markets close on: Wednesday, November 6, 2024 A conference call to discuss the results will be hosted by the ERES senior management team on: Thursday, November 7, 2024 at 9:00 am ET The telephone numbers for the conference call are: Canadian Toll Free: +1 (833) 950-0062 International: +1 (929) 526-1599 Access Code: 217681 The call will also be webcast live and accessible through the ERES website at www.eresreit.com – click on “Investor Info” and follow the link at the top of the page. A replay of the webcast will be available for one year after the webcast at the same link. The slide presentation...

Teledyne DALSA’s BOA3 smart cameraBOA3 smart cameras offer unmatched flexibility and functionality for quick, cost-effective machine vision deploymentsBOSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) — Teledyne DALSA, a Teledyne Technologies [NYSE:TDY] company and global leader in machine vision technology, is pleased to announce its next generation AI-powered BOA™3 smart camera for industrial automation and inspection. The new BOA3 smart camera is designed to leverage the best features from previous BOA generations and combine them with new sensor and AI (Artificial Intelligence) inspection technologies developed by Teledyne. BOA3 is a highly integrated vision system in a compact, rugged smart camera format designed to meet the needs of the most complex, demanding machine vision applications. “The new BOA3 is an exciting...

NOVATO, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it will present seven abstracts related to its ongoing late-stage program evaluating setrusumab (UX143) and osteogenesis imperfecta (OI), including a late-breaker oral presentation of the 14-month data from the Phase 2/3 Orbit study, at the American Society for Bone and Mineral Research (ASBMR) 2024 Annual Meeting. The meeting is being held September 27-30, 2024, in Toronto, Canada. “Presentations at this year’s ASBMR meeting add to our growing knowledge of the real-world impact and burden of OI and underscore the urgent need for an innovative therapy for these patients,” stated Eric Crombez, M.D., chief medical officer at Ultragenyx. “We will also present the phase 2 Orbit study results that we previously announced...

BOCA RATON, Fla., Sept. 26, 2024 (GLOBE NEWSWIRE) —  INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology and inflammation company, continues to advance its Natural Killer (NK) cell therapy, INKmune™, in a Phase I/II trial (the “CaRe PC” trial) for men with metastatic Castration-Resistant Prostate Cancer (mCRPC). The Company is pleased to announce initial results from the first patient cohort in the trial. Mark Lowdell, CSO and inventor of INKmune™, said, “The enrollment of the first cohort ran entirely in-line with our predicted timelines and confirmed the excellent safety profile with all patients receiving treatment as out-patient without the need for pre-medication of any kind. Furthermore, even at this lowest dose of INKmune™, there is clear evidence of persistent immunologic...

HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) — IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced the appointment of John Louis Fouts to its Board of Directors (“Board”), effective September 23, 2024. “We’re excited to welcome Lou to the Board,” said Jeff Gendell, IES’s Chairman and CEO. “Lou brings an extensive background in investment management and finance, and I’m confident that his knowledge, experience and perspective will make him a valuable addition to our Board.” Mr. Fouts has served as the managing member at Fouts Family Investments, a private investment holding company, since 2021. He also currently serves as a Trustee of the Georgia Tech Foundation and is the Chairman of its Investments Committee. From 2002 to 2021 he was a partner with Water Street Capital, Inc., a private investment firm located...

— Poster to be presented at ACR Convergence annual meeting — TAMPA, Fla., Sept. 26, 2024 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today announced the upcoming presentation of new data in support of its gene therapy candidate, PCRX-201 (enekinragene inzadenovec). The data will be presented at the American College of Rheumatology’s annual ACR Convergence meeting, being held in Washington, D.C. November 14–19. Presentation Title: Sustained Clinical Effects After a Single Intra-articular Injection of PCRX-201 for Moderate-to-Severe Osteoarthritis of the Knee Presented By: Stanley Cohen, MD, a board-certified rheumatologist and Co-Medical Director of the Metroplex Clinical Research Center in Dallas, TX Date & Time: Sunday,...

Cutting-Edge Gear to Empower Athletes in the Ultimate Endurance ChallengeStrategic Alliance Unites Innovation and Performance for Unprecedented Racing Success SANTA BARBARA, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) — DRYWORLD Brands Inc. (OTC: IBGR), a leading performance athletic brand, is excited to announce a ground-breaking partnership with Spartan Race, the global leader in extreme participation sports. The strategic alliance sees DRYWORLD become the exclusive and official compression partner of Spartan World Championships being held in Croatia and Greece in October and November respectively – it marks a significant milestone in both companies’ commitment to pushing the boundaries of athletic performance and innovation. Spartan Race, the global leader in extreme participation sports, is a series of obstacle races of varying...

PARIS, Sept. 26, 2024 (GLOBE NEWSWIRE) — Constellium is pleased to announce a partnership with Tesem, a global leader in luxury packaging, to advance sustainable aluminium production through an initiative called “Closing the Loop.” This collaboration underscores Constellium’s dedication to reducing environmental impact and promoting circular economy practices. Through this partnership, Constellium will work closely with Tesem to create a closed-loop system that enables the recycling of high-purity aluminium. Tesem has invested in enhancing their assets to ensure the efficient cleaning and preparation of aluminium scrap. Both companies’ R&D teams have collaborated to ensure the scrap meets the stringent quality standards required and to adjust casting parameters to integrate higher levels of recycled material. This...

NORWOOD, Mass., Sept. 26, 2024 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that the Company will participate in BMO Capital Markets’ Oncology Summit, to be held October 8, 2024 in New York, NY. Dr. Dominic Smethurst, MA MRCP, Chief Medical Officer of Corbus, will participate in a panel titled Capitalizing on Validated Mechanism in Oncology. Dr. Smethurst will also be joined by Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, to participate in one-on-one investor meetings. Panel Title: Capitalizing on Validated Mechanism in OncologyDate: Tuesday, October 8, 2024Presentation Time: 1:30 pm ET Please contact your BMO Capital Markets sales representative to register for the conference. About CorbusCorbus Pharmaceuticals Holdings, Inc. is an oncology company...

Designed to Accelerate it Insurance Business Boca Raton, FL, Sept. 26, 2024 (GLOBE NEWSWIRE) — Janover Inc. (Nasdaq:  JNVR) (“Janover” or the “Company”), an AI-enabled platform for commercial real estate transactions, today announced the launch of new AI tools to accelerate business development activities within its Insurtech subsidiary, Janover Insurance Group. The new tools include autonomous agents designed to reach out to as well as re-engage the Company’s extensive user database, which includes more than 100,000 contacts. The newly introduced features include advanced email and SMS capabilities, boosting the sales team’s effectiveness, while delivering a more streamlined, efficient experience for customers. The Company also plans to introduce a significantly more capable outbound AI application in Q4 2024 to actively...